cloxacillin has been researched along with ciprofloxacin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, DH; Lu, CD | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ashfaq, MK; Gross, A; Hamann, MT; Ibrahim, MA; Jacob, M; Khan, SI; Mansoor, AA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Amaral, L; Bojarski, AJ; Handzlik, J; Kieć-Kononowicz, K; Latacz, G; Matys, A; Molnar, J; Otrębska-Machaj, E; Podlewska, S; Schabikowski, J; Szymańska, E; Witek, J; Witek, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
| Fallara, A; Ravaoarinoro, M; Toma, E | 1 |
| Bevan, JS; Gibby, OM; Griffiths, GJ; Williams, JD | 1 |
| Alkan, M; Berger, S; Mark, Z; Rubinstein, E; Samra, Y | 1 |
| Glauser, MP; Malinverni, R; Perronne, CM | 1 |
| Broeders, PH; Goessens, WH; Michel, MF; Schmal-Bauer, WC; Thompson, J; Voorn, GP | 1 |
| Pons, G; Rey, E; Tréluyer, JM | 1 |
| Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ | 1 |
| Balraj, A; Job, A; Justus, A; Kirubakaran, CP; Paul, AC | 1 |
| Sudy, E | 1 |
| Freire, M; Graña, G; Losada, I; Rita, M | 1 |
| Cañada-Cañada, F; Espinosa-Mansilla, A; González Gómez, D; Muñoz de la Peña, A | 1 |
| Forsblom, E; Järvinen, A; Ruotsalainen, E | 1 |
| Messner, T; Schjøtt, J | 1 |
| Dilhari, A; Fernando, N; Gunasekara, C; McBain, A; Pathirage, S; Weerasekara, D; Weerasekera, M | 1 |
| Brodzka, A; Koszelewski, D; Kowalczyk, P; Kramkowski, K; Lizut, R; Ostaszewski, R; Szymczak, M; Trzepizur, D; Wypych, A | 1 |
2 review(s) available for cloxacillin and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug disposition in cystic fibrosis.
Topics: Absorption; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Cyclosporine; Cystic Fibrosis; Fleroxacin; Humans; Theophylline; Tissue Distribution | 1998 |
22 other study(ies) available for cloxacillin and ciprofloxacin
| Article | Year |
|---|---|
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore).
Topics: Anti-Bacterial Agents; Glycosides; Kaempferols; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mississippi; Molecular Structure; Stereoisomerism; Trees | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Imidazolidine-4-one derivatives in the search for novel chemosensitizers of Staphylococcus aureus MRSA: synthesis, biological evaluation and molecular modeling studies.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Imidazolidines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2015 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
Topics: beta-Lactamases; Cefazolin; Chloromercuribenzoates; Ciprofloxacin; Clavulanic Acids; Cloxacillin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Molecular Weight; Norfloxacin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry | 1992 |
Bilateral renal cortical abscesses in a young woman with type 1 diabetes.
Topics: Abscess; Adult; Cephradine; Ciprofloxacin; Cloxacillin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney Cortex; Kidney Diseases | 1989 |
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azlocillin; Bacteria; Cefamandole; Cefotaxime; Cefsulodin; Ciprofloxacin; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Mezlocillin; Penicillin Resistance; Proteus; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Shigella; Staphylococcus | 1986 |
Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
Topics: Aminocoumarins; Animals; Ciprofloxacin; Cloxacillin; Coumarins; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Rats; Staphylococcal Infections; Staphylococcus aureus | 1987 |
Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
Topics: Animals; Ciprofloxacin; Cloxacillin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Rats; Rats, Wistar; Serum Bactericidal Test; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence | 1999 |
Malignant otitis externa in an infant with selective IgA deficiency: a case report.
Topics: Child, Preschool; Ciprofloxacin; Cloxacillin; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Humans; IgA Deficiency; Metronidazole; Otitis Externa; Pseudomonas Infections; Tomography, X-Ray Computed | 2001 |
Pyoderma faciale: gram-negative recovery by means of needle aspiration.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Drainage; Enterobacter cloacae; Facial Dermatoses; Female; Gram-Negative Bacterial Infections; Humans; Isotretinoin; Klebsiella oxytoca; Male; Needles; Penicillins; Pyoderma; Staphylococcus aureus | 2002 |
[Relapsing Staphylococcus lugdunensis septic arthritis associated with a knee prosthesis].
Topics: Aged; Arthritis, Infectious; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Autoimmune Diseases; Ciprofloxacin; Cloxacillin; Drug Therapy, Combination; Fatal Outcome; Humans; Immunocompromised Host; Knee Prosthesis; Male; Phlebitis; Postoperative Complications; Prosthesis-Related Infections; Pulmonary Embolism; Recurrence; Rifampin; Staphylococcal Infections; Staphylococcus; Virulence | 2003 |
HPLC determination of ciprofloxacin, cloxacillin, and ibuprofen drugs in human urine samples.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Buffers; Chromatography, High Pressure Liquid; Ciprofloxacin; Cloxacillin; Humans; Hydrogen-Ion Concentration; Ibuprofen; Reference Standards | 2006 |
Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cloxacillin; Drug Therapy, Combination; Female; Finland; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Secondary Prevention; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Time-to-Treatment; Treatment Outcome | 2015 |
Ciprofloxacin and acute aortic valve damage.
Topics: Aged; Aortic Valve; Arthroplasty, Replacement, Knee; Ciprofloxacin; Cloxacillin; Collagen; Fluoroquinolones; Heart Valve Diseases; Humans; Male; Prosthesis-Related Infections; Rifampin; Tendinopathy | 2018 |
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefuroxime; Ciprofloxacin; Cloxacillin; Debridement; Diabetes Mellitus, Type 2; Female; Gram-Negative Bacterial Infections; Humans; Leg Ulcer; Microbial Sensitivity Tests; Paratyphoid Fever; Pseudomonas aeruginosa; Pseudomonas Infections; Salmonella paratyphi A; Wound Healing | 2020 |
The Synthesis and Evaluation of Diethyl Benzylphosphonates as Potential Antimicrobial Agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bleomycin; Ciprofloxacin; Cloxacillin; DNA, Bacterial; Escherichia coli; Esters; Microbial Sensitivity Tests; Organophosphonates; Palladium | 2022 |